Co-Diagnostics, Inc. (CODX) Financial Statements (2025 and earlier)
Company Profile
Business Address |
4049 SOUTH HIGHLAND DRIVE SALT LAKE CITY, UT 84124 |
State of Incorp. | UT |
Fiscal Year End | December 31 |
Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 58,548 | 81,263 | 89,863 | 47,312 | 893 | 950 | |||
Cash and cash equivalent | 14,917 | 22,974 | 88,607 | 42,977 | 893 | 950 | |||
Short-term investments | 43,632 | 58,289 | 1,255 | 4,335 | |||||
Receivables | 304 | 3,529 | 20,914 | 12,137 | 131 | 13 | |||
Inventory, net of allowances, customer advances and progress billings | 1,665 | 5,310 | 2,004 | 7,995 | 197 | 18 | |||
Inventory | 1,665 | 5,310 | 2,004 | 7,995 | 197 | 18 | |||
Prepaid expense | 2,338 | 369 | 363 | 70 | |||||
Other undisclosed current assets | 1,624 | 2,632 | 547 | ||||||
Total current assets: | 62,141 | 92,734 | 115,119 | 68,360 | 1,584 | 1,052 | |||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 2,967 | 372 | ✕ | ||||||
Property, plant and equipment | 3,036 | 2,539 | 1,933 | 950 | 197 | 156 | |||
Long-term investments and receivables | 75 | ||||||||
Long-term investments | |||||||||
Accounts and financing receivable, after allowance for credit loss | 75 | ||||||||
Intangible assets, net (including goodwill) | 26,404 | 26,768 | 41,902 | ||||||
Goodwill | 14,707 | ||||||||
Intangible assets, net (excluding goodwill) | 26,404 | 26,768 | 27,195 | ||||||
Other undisclosed noncurrent assets | 773 | 673 | 1,005 | 1,927 | 434 | 345 | |||
Total noncurrent assets: | 33,180 | 30,353 | 44,915 | 2,877 | 631 | 501 | |||
TOTAL ASSETS: | 95,321 | 123,086 | 160,034 | 71,237 | 2,215 | 1,553 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 3,655 | 1,887 | 6,680 | 4,085 | 207 | 323 | |||
Taxes payable | ✕ | ✕ | ✕ | 2,213 | |||||
Accounts payable | 1,482 | 952 | 608 | 598 | 6 | 149 | |||
Accrued liabilities | 2,173 | 934 | 3,860 | 3,487 | 201 | 174 | |||
Deferred revenue | 362 | 150 | 305 | ✕ | |||||
Debt | 1,909 | ||||||||
Due to related parties | ✕ | ✕ | 120 | 120 | 120 | ||||
Other undisclosed current liabilities | 1,730 | 1,987 | 5,767 | 1 | |||||
Total current liabilities: | 5,748 | 3,873 | 12,598 | 4,511 | 328 | 2,352 | |||
Noncurrent Liabilities | |||||||||
Liabilities, other than long-term debt | 2,152 | 2,469 | 7,228 | 30 | 150 | 260 | |||
Deferred income tax liabilities | 2,418 | 7,228 | ✕ | ||||||
Due to related parties | ✕ | ✕ | 30 | 150 | 260 | ||||
Operating lease, liability | 2,152 | 51 | ✕ | ||||||
Other undisclosed noncurrent liabilities | 1,407 | 2,224 | 5,733 | ||||||
Total noncurrent liabilities: | 3,559 | 4,693 | 12,962 | 30 | 150 | 260 | |||
Total liabilities: | 9,307 | 8,566 | 25,559 | 4,541 | 478 | 2,612 | |||
Equity | |||||||||
Equity, attributable to parent | 86,014 | 114,520 | 134,475 | 66,697 | 1,737 | (1,059) | |||
Preferred stock | 0 | ||||||||
Common stock | 36 | 35 | 34 | 29 | 17 | 13 | |||
Treasury stock, value | (15,576) | (14,212) | |||||||
Additional paid in capital | 96,808 | 88,473 | 80,272 | 49,157 | 26,688 | 17,622 | |||
Accumulated other comprehensive income | 147 | 293 | |||||||
Retained earnings (accumulated deficit) | 4,598 | 39,931 | 54,169 | 17,511 | (24,968) | (18,694) | |||
Total equity: | 86,014 | 114,520 | 134,475 | 66,697 | 1,737 | (1,059) | |||
TOTAL LIABILITIES AND EQUITY: | 95,321 | 123,086 | 160,034 | 71,237 | 2,215 | 1,553 |
Income Statement (P&L) ($ in thousands)
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 6,812 | 34,218 | 97,886 | 74,553 | 215 | 40 | ||
Realized investment gains | 2,243 | |||||||
Cost of revenue | (4,185) | (5,481) | (11,575) | (16,591) | (112) | (9) | ||
Cost of product and service sold | (3,233) | |||||||
Gross profit: | 2,627 | 28,737 | 86,311 | 57,961 | 103 | 31 | ||
Operating expenses | (45,333) | (55,717) | (40,246) | (16,268) | (5,996) | (6,148) | ||
Operating income (loss): | (42,706) | (26,980) | 46,065 | 41,694 | (5,894) | (6,118) | ||
Nonoperating income (expense) | 4,596 | 8,133 | (429) | 875 | (302) | (154) | ||
Investment income, nonoperating | (430) | 778 | ||||||
Other nonoperating expense | (302) | (154) | ||||||
Interest and debt expense | (106) | (135) | ||||||
Income (loss) from continuing operations before equity method investments, income taxes: | (38,111) | (18,847) | 45,636 | 42,569 | (6,302) | (6,407) | ||
Other undisclosed income from continuing operations before income taxes | 106 | 135 | ||||||
Income (loss) from continuing operations before income taxes: | (38,111) | (18,847) | 45,636 | 42,569 | (6,196) | (6,272) | ||
Income tax expense (benefit) | 2,778 | 4,609 | (8,977) | (91) | ||||
Income (loss) from continuing operations: | (35,333) | (14,238) | 36,659 | 42,479 | (6,196) | (6,272) | ||
Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | 36,659 | 42,479 | (6,196) | (6,272) | |
Net income (loss) available to common stockholders, diluted: | (35,333) | (14,238) | 36,659 | 42,479 | (6,196) | (6,272) |
Comprehensive Income ($ in thousands)
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | (35,333) | (14,238) | 36,659 | 42,479 | (6,196) | (6,272) | ||
Other comprehensive income (loss) | (146) | 293 | ||||||
Comprehensive income (loss), net of tax, attributable to parent: | (35,479) | (13,945) | 36,659 | 42,479 | (6,196) | (6,272) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.